Skip to main content

UBS Group AG

Position in IOVA — Iovance Biotherapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in IOVA

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$6,727,630
+$4,641,492 QoQ
Shares Held
1,916,704
+150.8% QoQ
Ownership
0.429%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 89.47803103661285.ToString("F0")% Shared 0.ToString("F0")% None 10.521968963387147.ToString("F0")%

Common Shares in IOVA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. IOVA ranks #124 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in IOVA

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $6,727,630 1,916,704
2025-12-31 $2,086,138 764,154
2025-09-30 $2,032,212 936,504
2025-06-30 $3,060,588 1,779,412
2025-03-31 $8,314,173 2,496,749
2024-12-31 $20,013,069 2,704,469
2024-09-30 $5,841,790 622,129
2024-06-30 $6,377,535 795,204
2024-03-31 $10,238,840 690,880
2023-12-31 $6,969,913 857,308
2023-09-30 $1,098,315 241,388
2023-06-30 $3,307,475 469,812
2023-03-31 $2,607,863 426,819
2022-12-31 $5,097,185 797,682
2022-09-30 $1,017,769 106,239
2022-06-30 $1,044,814 94,639
2022-03-31 $5,989,769 359,746
2021-12-31 $4,190,960 219,537
2021-09-30 $4,840,362 196,284
2021-06-30 $1,627,342 62,542
2021-03-31 $3,097,867 97,848
2020-12-31 $3,973,184 85,629
2020-09-30 $2,369,547 71,979
2020-06-30 $1,243,320 45,294
2020-03-31 $832,301 27,799